OVERVIEW

Turning Down the Heat: Exploring Newly Approved and Emerging Nonhormonal Therapies for Menopause-Associated VMS is organized by Answers in CME (AiCME).

Release Date: September 30, 2024
Expiration Date: September 29, 2025

Description:
In this activity, an expert in women's health and menopause discusses novel, nonhormonal strategies to treat vasomotor symptoms (VMS) associated with menopause.

Educational Objectives:
Upon completion of this activity, participants should be better able to:'

  • Recognize the rationale for novel nonhormonal therapies in the treatment of VMS associated with menopause
  • Review the clinical profiles of approved and emerging novel nonhormonal treatments of VMS associated with menopause
  • Outline patient-centered, evidence-based strategies to optimize the treatment of common menopausal symptoms.
Credits

Accreditation
Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Purdue University College of Pharmacy designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit™ into European CME credit (ECMEC) should contact the UEMS.

  • 0.5 AMA PRA Category 1 Credit™
  • TARGET AUDIENCE

    PhysicianCliniciansPharmaceuticalsObstetrics and Gynecology PhysiciansObstetriciansPrimary Care PhysiciansNurse Practitioners

    SPECIALITIES

    Obstetrics and GynecologyPrimary Care

    RELATED ONLINE COURSES